Research progress on the role and mechanism of action of exosomes in autoimmune thyroid disease

References

• Liu J, Jiang F, Jiang Y, et al. Roles of exosomes in ocular diseases. Int J Nanomedicine. 2020;15:10519–10538. doi:10.2147/IJN.S277190.
   PubMed Web of Science ®Google Scholar
• Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19):9412–9420. doi:10.1016/S0021-9258(18)48095-7.
   PubMed Web of Science ®Google Scholar
• Jayaseelan VP, Arumugam P. Dissecting the theranostic potential of exosomes in autoimmune disorders. Cell Mol Immunol. 2019;16(12):935–936. doi:10.1038/s41423-019-0310-5.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871(2):455–468. doi:10.1016/j.bbcan.2019.04.004.
   PubMed Web of Science ®Google Scholar
• Jiang C, Zhang N, Hu X, Wang H. Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms. Mol Cancer. 2021;20(1):117. doi:10.1186/s12943-021-01411-w.
   PubMed Web of Science ®Google Scholar
• Buschow SI, Nolte-’t Hoen EN, van Niel G, et al. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic. 2009;10(10):1528–1542. doi:10.1111/j.1600-0854.2009.00963.x.
   PubMed Web of Science ®Google Scholar
• Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487–514. doi:10.1146/annurev-biochem-013118-111902.
   PubMed Web of Science ®Google Scholar
• Huang Y, Li R, Ye S, Lin S, Yin G, Xie Q. Recent advances in the use of exosomes in Sjögren’s syndrome. Front Immunol. 2020;11(1509):1509.
   PubMedGoogle Scholar
• Wang Y, Xu F, Zhong JY, et al. Exosomes as mediators of cell-to-cell communication in thyroid disease. Int J Endocrinol. 2020;2020:4378345.
   PubMed Web of Science ®Google Scholar
• Villarroya-Beltri C, Baixauli F, Gutiérrez-Vázquez C, Sánchez-Madrid F, Mittelbrunn M. Sorting it out: regulation of exosome loading. Semin Cancer Biol. 2014;28:3–13. doi:10.1016/j.semcancer.2014.04.009.
   PubMed Web of Science ®Google Scholar
• Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113(1):1–11. doi:10.1007/s11060-013-1084-8.
   PubMed Web of Science ®Google Scholar
• Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33(3):967–978. doi:10.1016/0092-8674(83)90040-5.
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Exosomes and tumor-mediated immune suppression. J Clin Invest. 2016;126(4):1216–1223. doi:10.1172/JCI81136.
   PubMed Web of Science ®Google Scholar
• Miao C, Zhou W, Wang X, Fang J. The research progress of exosomes in osteoarthritis, with particular emphasis on the mediating roles of miRNAs and lncRNAs. Front Pharmacol. 2021;12:685623.
   PubMed Web of Science ®Google Scholar
• Chen JQ, Szodoray P, Zeher M. Toll-like receptor pathways in autoimmune diseases. Clin Rev Allergy Immunol. 2016;50(1):1–17. doi:10.1007/s12016-015-8473-z.
   PubMed Web of Science ®Google Scholar
• Shu SA, Wang J, Tao MH, Leung PS. Gene therapy for autoimmune disease. Clin Rev Allergy Immunol. 2015;49(2):163–176. doi:10.1007/s12016-014-8451-x.
   PubMed Web of Science ®Google Scholar
• Anaya JM. Common mechanisms of autoimmune diseases (the autoimmune tautology). Autoimmun Rev. 2012;11(11):781–784. doi:10.1016/j.autrev.2012.02.002.
   PubMed Web of Science ®Google Scholar
• Hu ZD, Deng AM. Autoantibodies in pre-clinical autoimmune disease. Clin Chim Acta. 2014;437:14–18. doi:10.1016/j.cca.2014.06.015.
   PubMed Web of Science ®Google Scholar
• Han MM, Yuan XR, Shi X, et al. The pathological mechanism and potential application of IL-38 in autoimmune diseases. Front Pharmacol. 2021;12:732790.
   PubMed Web of Science ®Google Scholar
• Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35(3):347–369. doi:10.1016/j.yfrne.2014.04.004.
   PubMed Web of Science ®Google Scholar
• Fugger L, Jensen LT, Rossjohn J. Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell. 2020;181(1):63–80. doi:10.1016/j.cell.2020.03.007.
   PubMed Web of Science ®Google Scholar
• Xiao ZX, Miller JS, Zheng SG. An updated advance of autoantibodies in autoimmune diseases. Autoimmun Rev. 2021;20(2):102743. doi:10.1016/j.autrev.2020.102743.
   PubMed Web of Science ®Google Scholar
• Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. 2018;19(7):665–673. doi:10.1038/s41590-018-0120-4.
   PubMed Web of Science ®Google Scholar
• Lei Y, Yang J, Li H, Zhong H, Wan Q. Changes in glucose-lipid metabolism, insulin resistance, and inflammatory factors in patients with autoimmune thyroid disease. J Clin Lab Anal. 2019;33(7):e22929. doi:10.1002/jcla.22929.
   PubMed Web of Science ®Google Scholar
• Song RH, Liu XR, Gao CQ, Du P, Zhang JA. METTL3 gene polymorphisms contribute to susceptibility to autoimmune thyroid disease. Endocrine. 2021;72(2):495–504. doi:10.1007/s12020-020-02503-1.
   PubMed Web of Science ®Google Scholar
• Tomer Y. Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics. Annu Rev Pathol. 2014;9:147–156. doi:10.1146/annurev-pathol-012513-104713.
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8(4):307. doi:10.3390/cells8040307.
   PubMed Web of Science ®Google Scholar
• Tavasolian F, Moghaddam AS, Rohani F, et al. Exosomes: effectual players in rheumatoid arthritis. Autoimmun Rev. 2020;19(6):102511. doi:10.1016/j.autrev.2020.102511.
   PubMed Web of Science ®Google Scholar
• Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684–3707. doi:10.7150/thno.41580.
   PubMed Web of Science ®Google Scholar
• Wang J, Ni J, Beretov J, Thompson J, Graham P, Li Y. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer. Crit Rev Oncol Hematol. 2020;145:102860. doi:10.1016/j.critrevonc.2019.102860.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Liu G, Li J. Recent progress on the isolation and detection methods of exosomes. Chem Asian J. 2020;15(23):3973–3982. doi:10.1002/asia.202000873.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine. 2020;15:6917–6934. doi:10.2147/IJN.S264498.
   PubMed Web of Science ®Google Scholar
• Zhu L, Sun HT, Wang S, et al. Isolation and characterization of exosomes for cancer research. J Hematol Oncol. 2020;13(1):152. doi:10.1186/s13045-020-00987-y.
   PubMed Web of Science ®Google Scholar
• Rider MA, Hurwitz SN, Meckes DG.Jr. ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles. Sci Rep. 2016;6:23978. doi:10.1038/srep23978.
   PubMed Web of Science ®Google Scholar
• Sidhom K, Obi PO, Saleem A. A review of exosomal isolation methods: is size exclusion chromatography the best option? IJMS. 2020;21(18):6466. doi:10.3390/ijms21186466.
   Google Scholar
• Zhao R, Zhao T, He Z, Cai R, Pang W. Composition, isolation, identification and function of adipose tissue-derived exosomes. Adipocyte. 2021;10(1):587–604. doi:10.1080/21623945.2021.1983242.
   PubMed Web of Science ®Google Scholar
• Helwa I, Cai J, Drewry MD, et al. A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLoS One. 2017;12(1):e0170628. doi:10.1371/journal.pone.0170628.
   PubMed Web of Science ®Google Scholar
• Chernyshev VS, Rachamadugu R, Tseng YH, et al. Size and shape characterization of hydrated and desiccated exosomes. Anal Bioanal Chem. 2015;407(12):3285–3301. doi:10.1007/s00216-015-8535-3.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhu Z, Gao J, et al. Plasma exosomal miR-375-3p regulates mitochondria-dependent keratinocyte apoptosis by targeting XIAP in severe drug-induced skin reactions. Sci Transl Med. 2020;12(574):eaaw6142.
   PubMed Web of Science ®Google Scholar
• Suh JH, Joo HS, Hong EB, Lee HJ, Lee JM. Therapeutic application of exosomes in inflammatory diseases. IJMS. 2021;22(3):1144–Published 2021 Jan 24. doi:10.3390/ijms22031144.
   Google Scholar
• Ng CY, Chai JY, Foo JB, et al. Potential of exosomes as cell-free therapy in articular cartilage regeneration: a review. Int J Nanomedicine. 2021;16:6749–6781. doi:10.2147/IJN.S327059.
   PubMedGoogle Scholar
• Zhu T, Wang Y, Jin H, Li L. The role of exosome in autoimmune connective tissue disease. Ann Med. 2019;51(2):101–108. doi:10.1080/07853890.2019.1592215.
   PubMed Web of Science ®Google Scholar
• Stuendl A, Kunadt M, Kruse N, et al. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies. Brain. 2016;139(Pt 2):481–494. doi:10.1093/brain/awv346.
   PubMedGoogle Scholar
• Peng C, Trojanowski JQ, Lee VM. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16(4):199–212. doi:10.1038/s41582-020-0333-7.
   PubMed Web of Science ®Google Scholar
• Zamani P, Fereydouni N, Butler AE, Navashenaq JG, Sahebkar A. The therapeutic and diagnostic role of exosomes in cardiovascular diseases. Trends Cardiovasc Med. 2019;29(6):313–323. doi:10.1016/j.tcm.2018.10.010.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhong J, Zhong B, et al. Exosomes as potential sources of biomarkers in colorectal cancer. Cancer Lett. 2020;476:13–22. doi:10.1016/j.canlet.2020.01.033.
   PubMed Web of Science ®Google Scholar
• Fu M, Gu J, Jiang P, Qian H, Xu W, Zhang X. Exosomes in gastric cancer: roles, mechanisms, and applications. Mol Cancer. 2019;18(1):41. Published 2019 Mar 15. doi:10.1186/s12943-019-1001-7.
   PubMed Web of Science ®Google Scholar
• Pang H, Luo S, Xiao Y, et al. Emerging roles of exosomes in T1DM. Front Immunol. 2020;11:593348.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13(1):17–24. doi:10.1016/j.gpb.2015.02.001.
   PubMed Web of Science ®Google Scholar
• Wong CH, Chen YC. Clinical significance of exosomes as potential biomarkers in cancer. World J Clin Cases. 2019;7(2):171–190. doi:10.12998/wjcc.v7.i2.171.
   PubMed Web of Science ®Google Scholar
• Guerra N, Tan YX, Joncker NT, Choy A, et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 2008;28(4):571–580. doi:10.1016/j.immuni.2008.02.016.
   PubMed Web of Science ®Google Scholar
• Gutzeit C, Nagy N, Gentile M, et al. Exosomes derived from Burkitt’s lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells. J Immunol. 2014;192(12):5852–5862. doi:10.4049/jimmunol.1302068.
   PubMed Web of Science ®Google Scholar
• Moroishi T, Hayashi T, Pan WW, et al. The hippo pathway kinases LATS1/2 suppress cancer immunity. Cell. 2016;167(6):1525–1539.e17. doi:10.1016/j.cell.2016.11.005.
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gerçel-Taylor C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer. 2005;92(2):305–311. doi:10.1038/sj.bjc.6602316.
   PubMed Web of Science ®Google Scholar
• Zhao L, Ma X, Yu J. Exosomes and organ-specific metastasis. Mol Ther Methods Clin Dev. 2021;22:133–147. doi:10.1016/j.omtm.2021.05.016.
   PubMed Web of Science ®Google Scholar
• Kourembanas S. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol. 2015;77:13–27. doi:10.1146/annurev-physiol-021014-071641.
   PubMed Web of Science ®Google Scholar
• Chinnappan M, Srivastava A, Amreddy N, et al. Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs. Cancer Lett. 2020;486:18–28. doi:10.1016/j.canlet.2020.05.004.
   PubMed Web of Science ®Google Scholar
• Deb A, Gupta S, Mazumder PB. Exosomes: A new horizon in modern medicine. Life Sci. 2021;264:118623. doi:10.1016/j.lfs.2020.118623.
   PubMed Web of Science ®Google Scholar
• Ferrari SM, Fallahi P, Elia G, et al. Thyroid autoimmune disorders and cancer. Semin Cancer Biol. 2020;64:135–146. doi:10.1016/j.semcancer.2019.05.019.
   PubMed Web of Science ®Google Scholar
• Ralli M, Angeletti D, Fiore M, et al. Hashimoto’s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10):102649. doi:10.1016/j.autrev.2020.102649.
   PubMed Web of Science ®Google Scholar
• Kahaly GJ, Diana T, Olivo PD. TSH receptor antibodies: relevance & utility. Endocr Pract. 2020;26(1):97–106. doi:10.4158/EP-2019-0363.
   PubMed Web of Science ®Google Scholar
• Li L, Liu S, Yu J. Autoimmune thyroid disease and type 1 diabetes mellitus: same pathogenesis; new perspective? Ther Adv Endocrinol Metab. 2020;11:2042018820958329. doi:10.1177/2042018820958329.
   Web of Science ®Google Scholar
• Ferrari SM, Elia G, Virili C, Centanni M, Antonelli A, Fallahi P. Systemic Lupus Erythematosus and Thyroid Autoimmunity. Front Endocrinol (Lausanne). 2017;8:138. doi:10.3389/fendo.2017.00138.
   PubMed Web of Science ®Google Scholar
• Conigliaro P, D’Antonio A, Pinto S, et al. Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay. Autoimmun Rev. 2020;19(6):102529. doi:10.1016/j.autrev.2020.102529.
   PubMed Web of Science ®Google Scholar
• Ito S, Fujiwara SI, Murahashi R, et al. Clinical association between thyroid disease and immune thrombocytopenia. Ann Hematol. 2021;100(2):345–352. doi:10.1007/s00277-020-04343-5.
   PubMed Web of Science ®Google Scholar
• Anaya JM, Restrepo-Jiménez P, Rodríguez Y, et al. Sjögren’s syndrome and autoimmune thyroid disease: two sides of the same coin. Clin Rev Allergy Immunol. 2019;56(3):362–374. doi:10.1007/s12016-018-8709-9.
   PubMed Web of Science ®Google Scholar
• Kim SY, Song YS, Wee JH, Min C, Yoo DM, Choi HG. Association between Ménière’s disease and thyroid diseases: a nested case-control study. Sci Rep. 2020;10(1):18224. doi:10.1038/s41598-020-75404-y.
   PubMed Web of Science ®Google Scholar
• De Leo S, Pearce EN. Autoimmune thyroid disease during pregnancy. Lancet Diabetes Endocrinol. 2018;6(7):575–586. doi:10.1016/S2213-8587(17)30402-3.
   PubMed Web of Science ®Google Scholar
• Salazar-Viedma M, Vergaño-Salazar JG, Pastenes L, D’Afonseca V. Simulation model for hashimoto autoimmune thyroiditis disease. Endocrinology. 2021;162(12):bqab190. doi:10.1210/endocr/bqab190.
   PubMed Web of Science ®Google Scholar
• Rayman MP. Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc Nutr Soc. 2019;78(1):34–44. doi:10.1017/S0029665118001192.
   PubMed Web of Science ®Google Scholar
• Miao C, Wang X, Zhou W, Huang J. The emerging roles of exosomes in autoimmune diseases, with special emphasis on microRNAs in exosomes. Pharmacol Res. 2021;169:105680. doi:10.1016/j.phrs.2021.105680.
   PubMed Web of Science ®Google Scholar
• Jan AT, Rahman S, Badierah R, et al. Expedition into exosome biology: a perspective of progress from discovery to therapeutic development. Cancers (Basel). 2021;13(5):1157. doi:10.3390/cancers13051157.
   PubMed Web of Science ®Google Scholar
• Ragusa F, Fallahi P, Elia G, et al. Hashimotos’ thyroiditis: epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101367. doi:10.1016/j.beem.2019.101367.
   PubMed Web of Science ®Google Scholar
• Ye SB, Li ZL, Luo DH, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5(14):5439–5452. doi:10.18632/oncotarget.2118.
   PubMedGoogle Scholar
• Rodríguez-Muñoz A, Martínez-Hernández R, Ramos-Leví AM, Serrano-Somavilla A, et al. Circulating microvesicles regulate treg and Th17 differentiation in human autoimmune thyroid disorders. J Clin Endocrinol Metab. 2015;100(12):E1531–E1539. doi:10.1210/jc.2015-3146.
   PubMed Web of Science ®Google Scholar
• De Maio A, Vazquez D. Extracellular heat shock proteins: a new location, a new function. Shock. 2013;40(4):239–246. doi:10.1097/SHK.0b013e3182a185ab.
   PubMed Web of Science ®Google Scholar
• Cui X, Liu Y, Wang S, et al. Circulating exosomes activate dendritic cells and induce unbalanced CD4+ T cell differentiation in hashimoto thyroiditis. J Clin Endocrinol Metab. 2019;104(10):4607–4618. doi:10.1210/jc.2019-00273.
   PubMed Web of Science ®Google Scholar
• Cui X, Wang S, Zhao N, et al. Thyrocyte-derived exosome-targeted dendritic cells stimulate strong CD4+ T lymphocyte responses. Mol Cell Endocrinol. 2020;506:110756. doi:10.1016/j.mce.2020.110756.
   PubMed Web of Science ®Google Scholar
• Vlasov P, Doi SQ, Sellitti DF. FRTL-5 rat thyroid cells release thyroglobulin sequestered in exosomes: a possible novel mechanism for thyroglobulin processing in the thyroid. J Thyroid Res. 2016;2016:9276402. doi:10.1155/2016/9276402.
   PubMedGoogle Scholar
• Jia X, Zhai T, Zhang JA. Circulating exosome involves in the pathogenesis of autoimmune thyroid diseases through immunomodulatory proteins. Front Immunol. 2021;12:730089.
   PubMed Web of Science ®Google Scholar
• Mariani G, Tonacchera M, Grosso M, Orsolini F, Vitti P, Strauss HW. The role of nuclear medicine in the clinical management of benign thyroid disorders, Part 1: Hyperthyroidism. J Nucl Med. 2021;62(3):304–312. doi:10.2967/jnumed.120.243170.
   PubMed Web of Science ®Google Scholar
• (a) Hasham A, Tomer Y, Genetic and epigenetic mechanisms in thyroid autoimmunity. N Engl J Med. 2012;375(16):1552–213. (b) Smith TJ, Hegedüs L. Graves’ disease. N Engl J Med. 2016;375(16):1552–1565. doi:10.1056/NEJMra1510030.
   Google Scholar
• Giuliani C, Cerrone D, Harii N, et al. A TSHr-LH/CGr chimera that measures functional TSAb in Graves’ disease. J Clin Endocrinol Metab. 2012;97(7):E1106–E1115. doi:10.1210/jc.2011-2893.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Fallahi P, Elia G, et al. Graves’ disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101388. doi:10.1016/j.beem.2020.101388.
   PubMed Web of Science ®Google Scholar
• Kahaly GJ. Management of graves thyroidal and extrathyroidal disease: an update. J Clin Endocrinol Metab. 2020;105(12):3704–3720. doi:10.1210/clinem/dgaa646.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Ferrari SM, Ragusa F, et al. Graves’ disease: epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101387. doi:10.1016/j.beem.2020.101387.
   PubMed Web of Science ®Google Scholar
• Taheri M, Eghtedarian R, Dinger ME, Ghafouri-Fard S. Dysregulation of non-coding RNAs in autoimmune thyroid disease. Exp Mol Pathol. 2020; Dec117:104527. doi:10.1016/j.yexmp.2020.104527.
   PubMed Web of Science ®Google Scholar
• Yin L, Zeng C, Yao J, Shen J. Emerging roles for noncoding RNAs in autoimmune thyroid disease. Endocrinology. 2020;161(8):bqaa053. doi:10.1210/endocr/bqaa053.
   PubMed Web of Science ®Google Scholar
• Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012;7(3):e30679. doi:10.1371/journal.pone.0030679.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108(12):5003–5008. doi:10.1073/pnas.1019055108.
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39(16):7223–7233. doi:10.1093/nar/gkr254.
   PubMed Web of Science ®Google Scholar
• Okoye IS, Coomes SM, Pelly VS, et al. MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity. 2014;41(1):89–103. doi:10.1016/j.immuni.2014.05.019.
   PubMed Web of Science ®Google Scholar
• Mirzaei R, Zamani F, Hajibaba M, et al. The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases. J Neuroimmunol. 2021;358:577640. doi:10.1016/j.jneuroim.2021.577640.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654–659. doi:10.1038/ncb1596.
   PubMed Web of Science ®Google Scholar
• Hiratsuka I, Yamada H, Munetsuna E, Hashimoto S, Itoh M. Circulating MicroRNAs in Graves’ disease in relation to clinical activity. Thyroid. 2016;26(10):1431–1440. doi:10.1089/thy.2016.0062.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang W, Tang Y, et al. Microarray profiling and functional analysis of differentially expressed plasma exosomal circular RNAs in Graves’ disease. Biol Res. 2020;53(1):32. doi:10.1186/s40659-020-00299-y.
   PubMed Web of Science ®Google Scholar
• Mobarrez F, Abraham-Nordling M, Aguilera-Gatica K, et al. The expression of microvesicles in the blood of patients with Graves’ disease and its relationship to treatment. Clin Endocrinol. 2016;84(5):729–735. doi:10.1111/cen.12872.
   PubMed Web of Science ®Google Scholar
• Cianciaruso C, Phelps EA, Pasquier M, et al. Primary human and Rat β-cells release the intracellular autoantigens GAD65, IA-2, and proinsulin in exosomes together with cytokine-induced enhancers of immunity. Diabetes. 2017;66(2):460–473. doi:10.2337/db16-0671.
   PubMed Web of Science ®Google Scholar
• Rossi M, Taddei AR, Fasciani I, Maggio R, Giorgi F. The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT). J Endocrinol Invest. 2018;41(1):67–73. doi:10.1007/s40618-017-0716-9.
   PubMed Web of Science ®Google Scholar
• Edo N, Kawakami K, Fujita Y, et al. Exosomes expressing thyrotropin receptor attenuate autoantibody-mediated stimulation of cyclic adenosine monophosphate production. Thyroid. 2019;29(7):1012–1017. doi:10.1089/thy.2018.0772.
   PubMed Web of Science ®Google Scholar
• Cui X, Huang M, Wang S, et al. Circulating exosomes from patients with graves’ disease induce an inflammatory immune response. Endocrinology. 2021;162(3):bqaa236. doi:10.1210/endocr/bqaa236.
   PubMed Web of Science ®Google Scholar
• Zou J, Peng H, Liu Y. The roles of exosomes in immunoregulation and autoimmune thyroid diseases. Front Immunol. 2021;12:757674.
   PubMed Web of Science ®Google Scholar
• Leray B, Imbert P, Thouvenin D, Boutault F, Caron P. Prise en charge diagnostique et thérapeutique d’une orbitopathie dysthyroïdienne: une affection multidisciplinaire [Diagnosis and treatment of dysthyroid orbitopathy: a multidisciplinary disease]. J Fr Ophtalmol. 2013;36(10):874–885. doi:10.1016/j.jfo.2013.07.004.
   PubMedGoogle Scholar
• Han JS, Kim SE, Jin JQ, et al. Tear-derived exosome proteins are increased in patients with thyroid eye disease. IJMS. 2021;22(3):1115. doi:10.3390/ijms22031115.
   Google Scholar